Budd-Chiari syndrome in a patient with acute promyelocytic leukaemia
Diffuse bone marrow uptake of fluorodeoxyglucose in a patient with aleukaemic acute lymphoblastic leukaemia
How I determine if and when to recommend stopping tyrosine kinase inhibitor treatment for chronic myeloid leukaemia
Breaking good: the inexorable rise of BTK inhibitors in the treatment of chronic lymphocytic leukaemia
A critical review of which children with acute myeloid leukaemia need stem cell procedures
Guidelines for the first line management of classical Hodgkin lymphoma
Peripheral blood 8 colour flow cytometry monitoring of hairy cell leukaemia allows detection of high-risk patients
Prognostic significance of soft tissue extension, International Prognostic Index, and multifocality in primary bone lymphoma: a single institutional experience
Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group
Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first-relapse/primary refractory diffuse large B-cell lymphoma
Loss of function tp53 mutations do not accelerate the onset of myc -induced T-cell acute lymphoblastic leukaemia in the zebrafish
Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphoma
SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma – a Nordic Lymphoma Group study
Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results
A phase II study of dose-dense and dose-intense ABVD (ABVDDD-DI) without consolidation radiotherapy in patients with advanced Hodgkin lymphoma
Clinical presentation and molecular basis of congenital antithrombin deficiency in children: a cohort study
Bendamustine for Hodgkin lymphoma patients failing autologous or autologous and allogeneic stem cell transplantation: a retrospective study of the Fondazione Italiana Linfomi
Haemophagocytic lymphohistiocytosis following fludarabine/cyclophosphamide chemotherapy for chronic lymphocytic leukaemia
Elevated plasma 2-hydroxyglutarate in acute myeloid leukaemia: association with the IDH1 SNP rs11554137 and severe renal impairment
Missense single nucleotide polymorphisms in the human T cell receptor loci control variable gene usage in the T cell repertoire
Activated prothrombin complex concentrate for the prevention of dabigatran- associated bleeding